COVID-19 vaccination in Senegal

Last updated

COVID-19 vaccination in Senegal
Date23 February 2021 - present
Location Senegal
Cause COVID-19 pandemic

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. [1] As of 10 March, 68,205 people in Senegal have been able to be vaccinated. [2] [3]

Contents

History

Timeline

February 2021

On 23 February 2021, [4] Senegal began its national vaccination program against COVID-19 using the Sinopharm BIBP vaccine. [5]

March 2021

By the end of the month 309,128 vaccine doses had been administered, including 260,754 first doses.

April 2021

By the end of the month 470,009 vaccine doses had been administered, including 406,981 first doses.

May 2021

By the end of the month more than half a million vaccine doses had been administered, including 456,135 first doses.

June 2021

By the end of the month 0.7 million vaccine doses had been administered, including 0.5 million first doses.

July 2021

By the end of the month 1.1 million vaccine doses had been administered while 806,510 persons had been vaccinated. [6]

August 2021

By the end of the month 1.6 million vaccine doses had been administered while 1,167,364 persons had been vaccinated. [7]

September 2021

By the end of the month 1.8 million vaccine doses had been administered while 1,251,403 persons had been vaccinated. [8]

October 2021

By the end of the month 1.9 million vaccine doses had been administered, including 1.3 million first doses, and 13% of the target population had been fully vaccinated.

November 2021

By the end of the month 1.9 million vaccine doses had been administered, including 1.3 million first doses, and 13% of the target population had been fully vaccinated.

Vaccine in order

VaccineApprovalDeployment
Sinopharm BIBP Green check.svg YesGreen check.svg 23 February 2021
Oxford–AstraZeneca Green check.svg YesGreen check.svg Yes

Progress

Cumulative vaccinations [3] The following figure presents the cumulative number of people in Senegal who have been vaccinated (vertical axis) since the starting date of vaccinations in Senegal (horizontal axis: date)

Related Research Articles

COVID-19 pandemic in Senegal Ongoing COVID-19 viral pandemic in Senegal

The COVID-19 pandemic in Senegal is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Senegal on March 2, 2020.

Sinopharm BIBP COVID-19 vaccine Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Zimbabwe

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 3 December 2021, 3,844,394 people have received their first dose, and 2,864,851 people have received their second dose.

On 29 January 2021, Algeria launched a coronavirus vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Burkina Faso

Burkina Faso started vaccinating against COVID-19 on 2 June 2021.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Ghana

COVID-19 vaccination in Ghana began on Monday 1 March 2021 after the country became the first recipient of the Oxford-AstraZeneca COVID-19 vaccine as part of the COVAX initiative. As of 6 June 2021, Ghana has administered 1,230,000 vaccine doses.

COVID-19 vaccination in Nigeria Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 19 November 2021, 6,021,560 people have received their first dose a COVID-19 vaccine, and 3,369,628 people have received their second dose.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Burundi is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Cameroon is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Chad is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in the Democratic Republic of the Congo is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The following is a timeline of the COVID-19 pandemic in Ivory Coast.

References

  1. AfricaNews (18 February 2021). "Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm". Africanews. Retrieved 12 March 2021.
  2. "One year after the start of the pandemic in Senegal, the country will receive a first batch of 324,000 doses of COVID-19 vaccine through the COVAX initiative - Senegal". ReliefWeb. Retrieved 12 March 2021.
  3. 1 2 "owid/covid-19-data". GitHub. Retrieved 12 March 2021.
  4. AfricaNews (23 February 2021). "Senegal begins covid-19 vaccination with doses from China's Sinopharm". Africanews. Retrieved 12 March 2021.
  5. "Senegal: total COVID-19 vaccine doses 2021". Statista. Retrieved 12 March 2021.
  6. "Sénégal : 1045 nouveaux cas testés positifs au coronavirus, 382 nouveaux guéris, 20 nouveaux décès et 76 cas graves en réanimation". Dakaractu (in French). 31 July 2021. Retrieved 2 August 2021.
  7. Ndaw, Amadou (31 August 2021). "31 août au Sénégal: 52 nouveaux cas, 05 décès, 31 cas graves pour 72.805 cas au total". Dakar-Echo (in French). Retrieved 1 September 2021.
  8. "Covid-19Sn: aucun cas de décès, 11 nouvelles contaminations et 6 cas graves en réanimation". PressAfrik (in French). 30 September 2021. Retrieved 10 October 2021.